When comparing mean tumor volumes in re-challenged mice, CD8-depleted mice displayed significantly larger tumors beginning on day 22 post-tumor rechallenge (p<0.05, one-way ANOVA followed by Tukey’s multiple comparisons test) (Fig 6A). This evidence concerns the gene CD8A and neoplasm.